Pharmy

Pharmy

By idan karbat

Pharmy is a price-comparison tool for pharmacy and cosmetic products in Israel, available on iOS and Android.

The App DNA

What makes this app unique?

The service removes the cognitive cost of manual price checking across multiple retail chains by automating cost calculations for shopping lists.

For Israeli consumers looking to compare prices on pharmacy and cosmetic products to minimize household spending.

What does it look like?

Key features

Smart Cart Recommendationedge

Calculates the lowest total cost for a list of products across multiple pharmacy chains.

Barcode Scannerstandard

Scans physical product barcodes to retrieve real-time price comparisons from nearby stores.

Community Group Purchasesedge

Enables users to join group buying events for exclusive pricing on selected items.

How much does it cost?

freeFree access to all features

The app is currently free with no IAP or subscription tiers, focusing on user acquisition and community growth.

Velocity

Maintenance developmentperformanceopaqueShow more...

Pharmy maintains a maintenance-level cadence, shipping only one release in the observed window. The latest release provides only generic bug fixes, indicating a lack of new feature development or live operations. With the last update occurring 38 days ago, the development cycle remains focused exclusively on stability and performance maintenance.

See all version history

Who built it?

idan karbat

2 apps tracked · Shopping

PharmyPharmy
Explore the full publisher profile

User Sentiment

What do users think recently?

The recent review mood reads frustrated. Users appreciate the core application functionality provides a useful utility for users who successfully navigate the initial setup.

How are ratings & reviews evolving?

App Store
0.00 · 0
Google Play
0.00 · 0

What users say, by theme

What Users Love
  • The core application functionality provides a useful utility for users who successfully navigate the initial setup
What Frustrates Users
  • Frequent application crashes prevent users from accessing the interface entirely following the latest update
+ 2 more themes
What Users Want 1 request inside

5 of 5 recent reviews analyzed · limited sample

Read the full review analysis

Unlock 2 more frustration themes and 1 user request, each backed by review evidence.

Access the full report for free

Competition

Competitive landscape for Pharmy

How's the Shopping market?

Pharmy currently holds the #37 position on the Top Free Shopping chart in Israel. The lack of monetization tiers suggests a focus on scale, though the current technical instability limits the conversion of discovery into active daily usage.

Read the market outlook

The rivals identified

idealo: Price Comparison App

By idealo internet GmbH

Both apps target price-sensitive shoppers by aggregating retail data to identify the lowest cost for a shopping list. They compete directly for users seeking to minimize household spending through product comparison.

  • idealo provides price history tracking and automated alerts for product drops, while Pharmy focuses on cart calculation.
  • idealo includes expert product reviews and data sheets, whereas Pharmy relies on barcode scanning for local retail chains.
Pharmy vs idealo: Price Comparison App

Unlock the head-to-head verdict: where this rival wins, and where it loses.

Access the full report for free

The Analyst's Read

Key takeaways for Pharmy

Where is it heading?

The price-comparison market in Israel is consolidating around services that offer high-frequency data accuracy and broad retail coverage. Pharmy's current maintenance-only posture leaves it exposed to churn, as the technical instability prevents users from realizing the value of the smart cart feature.

  • Frequent launch-time crashes prevent users from accessing the interface, which erodes the daily active habit and drives negative sentiment.
  • Maintenance-only update cadence without feature expansion suggests the developer is not actively addressing the database coverage gaps requested by users.

The SWOT

Core Strengths
  • Smart cart recommendation engine provides a clear utility-based barrier to entry
Critical Frictions 2 weaknesses inside
Growth Levers
  • Expanding database to include discount supermarket chains increases household spending relevance
Market Threats 1 threat identified

Next best moves

1 Invest · 1 Maintain

Rebuild launch sequence because launch-time crashes are the top-reported barrier to entry → increase daily active habit

+ 1 more prioritized move

The counter-intuitive read

The lack of monetization is a liability, not an asset: without revenue…

Read the full take

Since the last report: The outlook for Pharmy has declined as the app remains in a maintenance-only state, failing to address critical launch-time crashes or expand retail database coverage. The lack of monetization is now explicitly identified as a structural barrier to maintaining the data accuracy required for market competition.

Bottom line

Pharmy provides a clear utility for price-conscious shoppers, but the high frequency of launch-time crashes currently prevents the service from retaining its user base. Prioritizing stability over new feature development would secure the retention loop necessary to compete in the price-comparison space.

Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.

Access the full report for free

FAQ

Is Pharmy free to use?
Yes, Pharmy is currently free to use with no subscription or in-app purchase tiers, as the developer is focusing on user acquisition.
Does Pharmy work for all retail chains in Israel?
Pharmy currently covers major pharmacy and cosmetic chains like Super-Pharm, Be, and Good Pharm, but users have requested the addition of more discount supermarket chains.
Is Pharmy safe to use for price comparisons?
Pharmy provides a utility for comparing prices, but users report technical issues such as app crashes and missing UI elements that may affect the reliability of the service.

Sources

  1. [1] Play Store reviews
  2. [2] App Store

Report last updated

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by Pharmy, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

What's new

The outlook for Pharmy has declined as the app remains in a maintenance-only state, failing to address critical launch-time crashes or expand retail database coverage. The lack of monetization is now explicitly identified as a structural barrier to maintaining the data accuracy required for market competition.

shifted

Monetization as a structural liability

added

Competitive vulnerability to rivals

declined

Outlook trend downgrade

Cite this report

Marlvel.ai. “Pharmy Intelligence Report.” Updated Sep 5, 2026. https://marlvel.ai/apps/pharmy

Agent Markdown (.md)See methodologyContact support

Data licensed under CC-BY-NC 4.0